Empirical Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $569K | Hold |
6,857
| – | – | 0.18% | 188 |
|
|
2025
Q1 | $556K | Sell |
6,857
-2,454
| -26% | -$199K | 0.19% | 161 |
|
|
2024
Q4 | $620K | Sell |
9,311
-630
| -6% | -$42K | 0.21% | 140 |
|
|
2024
Q3 | $742K | Sell |
9,941
-39
| -0.4% | -$2.91K | 0.26% | 111 |
|
|
2024
Q2 | $700K | Buy |
9,980
+2,346
| +31% | +$165K | 0.26% | 108 |
|
|
2024
Q1 | $724K | Buy |
+7,634
| New | +$724K | 0.35% | 78 |
|
|
2023
Q1 | – | Sell |
-10,883
| Closed | -$903 | – | 204 |
|
|
2022
Q4 | $903 | Buy |
+10,883
| New | +$903 | ﹤0.01% | 159 |
|